| ²é¿´: 214 | »Ø¸´: 1 | ||
ldlľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
άÆ×ÇóÖú£¬Ð»Ð» ÒÑÓÐ1È˲ÎÓë
|
|
̼Æ×£º26.1,30.8,101.5,113.5,120.3,121.7,122.7,130.4,138.7 ¿ÉÄÜ»¹ÓÐû³öÀ´µÄ£¬¸ß·Ö±æ·Ö×Óʽ£ºC13H10N2O |
» ²ÂÄãϲ»¶
332Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ29È˻ظ´
²ÄÁÏÓ뻯¹¤µ÷¼Á
ÒѾÓÐ14È˻ظ´
291 Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
»úеר˶270Çóµ÷¼Á£¬½ÓÊÜ¿çרҵ
ÒѾÓÐ11È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ
ÒѾÓÐ8È˻ظ´
»¯Ñ§¹¤³ÌÓë¼¼Êõ324µ÷¼Á
ÒѾÓÐ23È˻ظ´
²ÄÁÏ085601µ÷¼Á
ÒѾÓÐ15È˻ظ´
269Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
´óÉñ£¬ËÓÐ2-ôÇ»ù-4-¼×Ñõ»ùÈâ¹ðËá
ÒѾÓÐ7È˻ظ´
Çó½âÎöNOESY¶þάÆ×
ÒѾÓÐ9È˻ظ´
MestReNove´¦Àí¶þάÆ×
ÒѾÓÐ10È˻ظ´
ÖÊÆ×ÐźÅ15¿ÉÄÜ»áÊÇʲô
ÒѾÓÐ3È˻ظ´
MestReNovaÕâ¸öºË´ÅÈí¼þ£¬ÈçºÎÔÚ¶þάÆ×ÉÏÃæºÍ×ó±ß¼ÓÉÏÇâÆ×ºÍ̼Æ×µÄһά
ÒѾÓÐ6È˻ظ´
Chemical and Pharmaceutical BulletinÔõô½»·Ñ
ÒѾÓÐ5È˻ظ´
ºìÍâÏàËÆ¶ÈÇóÖú
ÒѾÓÐ6È˻ظ´
ÇóÖúº£ÇøÐü¸¡¿ÅÁ£Îï¹ýÂËÑ¡ÓÃÄÄÖÖÀàÐ͵IJ£Á§ÏËάÂËĤ~~лл£¡£¡£¡
ÒѾÓÐ2È˻ظ´
άÆ×Êý¾Ý²éѯÇóÖú£¬¡µ70%
ÒѾÓÐ4È˻ظ´
ÓÃCDÆ×ÅжϾø¶Ô¹¹Ð͵ÄÎÊÌâ
ÒѾÓÐ5È˻ظ´
ÇóÖú΢Æ×Êý¾Ý4¸ö
ÒѾÓÐ4È˻ظ´
ÇóÖúάÆ×Êý¾Ý£¬¿ÉÄÜÊǽṹºÜ¶Ô³ÆµÄ»¯ºÏÎï
ÒѾÓÐ3È˻ظ´
ÓÐľÓнâÆ×µÄ¸ßÊÖÀ´Ì½ÌÖ¸ö¹ØÓÚ¶þάÆ×ͼµÄÎÊÌ⣿
ÒѾÓÐ8È˻ظ´
΢Æ×Êý¾ÝÇóÖú£¡
ÒѾÓÐ14È˻ظ´
ÇóÖúάÆ×Êý¾Ý¿â
ÒѾÓÐ5È˻ظ´
Âé·³¸÷λ°ïÎÒÔÚ¡°Î¬Æ×Êý¾Ý¡±ÖвéÕÒÒ»ÏÂÕâ¸ö»¯ºÏÎ
ÒѾÓÐ3È˻ظ´
[ÇóÖú]ÄÄλºÃÈËѧУ¿ÉÒÔʹÓÃ΢Æ×Êý¾Ý¿â£¬°ïÎÒ¼ìË÷¼¸¸ö»¯ºÏÎïµÄĸºË¡£Ð»Ð»£¡
ÒѾÓÐ4È˻ظ´
½âÆ× ¾Ñé ÎÊÌâ ÇóÖú
ÒѾÓÐ5È˻ظ´
¡¾½»Á÷¡¿¹ØÓÚ¶þάÆ×µÄÓйؽâÆ×¹æÂɺͼ¼ÇÉ
ÒѾÓÐ25È˻ظ´
¡¾ÇóÖú¡¿ÒÒ»ùÏËÎ¬ËØ¼°Æä¸ÄÐÔ²úÎïXRDÆ×ͼ½âÎö
ÒѾÓÐ6È˻ظ´
¡¾ÇóÖú¡¿Ì¼ÏËάµÄ±ê×¼ºìÍâ¹âÆ×ͼ
ÒѾÓÐ12È˻ظ´
yangyinhe
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 1566 (½²Ê¦)
- ½ð±Ò: 15048.4
- ºì»¨: 21
- Ìû×Ó: 2773
- ÔÚÏß: 261.2Сʱ
- ³æºÅ: 942922
- ×¢²á: 2010-01-15
- ÐÔ±ð: MM
- רҵ: ÌìÈ»Óлú»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ldl: ½ð±Ò+10, ¡ïÓаïÖú 2015-05-11 21:31:20
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ldl: ½ð±Ò+10, ¡ïÓаïÖú 2015-05-11 21:31:20
|
1 . compound 12 ÏàËÆ¶È:60% Acta Pharmaceutica Sinica 2001 Vol 36 590-594 CHEMICAL CONSTITUENTS OF DIURANTHERA INARTICULATA YANG Wei li; TIAN Jun; PENG Shu lin; GUAN Jia fa; DING Li sheng Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 2 . 2-(3-nitrophenyl)-1H-benzimidazole ÏàËÆ¶È:60% Indian Journal of Chemistry Section B 2007 46B 349-351 TiCl₄ Promoted synthesis of benzimidazole derivatives Nagawade,Rahul R; Shinde,Devanand B Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 3 . 2-(1H-indol-2-yl)propane-1,3-diamine ÏàËÆ¶È:60% European Journal of Organic Chemistry 2010 484-493 Synthesis of Optically Active Heterocyclic Compounds by Preparation of 1,3-Dinitro Derivatives and Enzymatic Enantioselective Desymmetrization of Prochiral Diamines Nicol¨¢s R¨ªos-Lombard¨ªa, Eduardo Busto, Vicente Gotor-Fern¨¢ndez and Vicente Gotor Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 4 . compound 4 ÏàËÆ¶È:60% Canadian Journal of Chemistry 1980 58 60-64 N-(tert-Butyldimethylsilyl)imidazole and related heterocycles: 13C nuclear magnetic resonance study and reaction with dimethylsulfoxide Alexander F. Janzen, Gerald N. Lypka, Roderick E. Wasylishen Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 5 . 1-(4-Chlorophenyl)-4-((1-(4-chlorophenyl)-3-(trifluoromethyl)-5-hydroxy-1H-pyrazol-4-yl)(4-methoxyphenyl)methyl)-3-(trifluoromethyl)-1H-pyrazol-5-ol C28H18Cl2F6N4O3 ÏàËÆ¶È:60% Medicinal Chemistry Research 2014 23 158¨C167 Synthesis and antibacterial activity of 4,4¡ä-(aryl or alkyl methylene)-bis(1H-pyrazol-5-ol) derivatives S. Bhavanarushi, V. Kanakaiah, Gandu Bharath, A. Gangagnirao, J. Vatsala Rani Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ -------------------------------------------------------------------------------- 6 . 2-(1H-indol-3-yl) ethanol ÏàËÆ¶È:60% Journal of Chinese Medicinal Materials 2013 36 11111-11112 ·äº£ÃàHaliclona sp. µÄ»¯Ñ§³É·ÖÑо¿ ÀîÔÆÇï, Íõ±ö, ÁõÓÀºê* Structure 13C NMR Structure & 13C NMR ̼Æ×Ä£Äâͼ |
2Â¥2015-05-11 09:02:05













»Ø¸´´ËÂ¥